American Century Companies Inc Editas Medicine, Inc. Transaction History

American Century Companies Inc

$167 Billion
Q3 2024

A detailed history of American Century Companies Inc transactions in Editas Medicine, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 147,971 shares of EDIT stock, worth $198,281. This represents 0.0% of its overall portfolio holdings.

Number of Shares

147,971

Previous 126,240 17.21%

Holding current value

$198,281

Previous $589,000 14.43%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$3.39 - $5.96 $73,668 - $129,516	21,731 Added 17.21%	147,971 $504,000
Q2 2024 Aug 07, 2024	BUY	$4.67 - $7.28 $70,460 - $109,840	15,088 Added 13.57%	126,240 $589,000
Q1 2024 May 14, 2024	BUY	$7.03 - $11.07 $204,530 - $322,070	29,094 Added 35.46%	111,152 $824,000
Q4 2023 Feb 13, 2024	BUY	$6.25 - $11.11 $512,862 - $911,664	82,058 New	82,058 $831,000
Q3 2023 Nov 13, 2023	BUY	$6.92 - $9.31 $134,600 - $181,088	19,451 Added 56.61%	53,808 $419,000
Q2 2023 Aug 14, 2023	BUY	$6.36 - $11.47 $107,019 - $193,005	16,827 Added 95.99%	34,357 $282,000
Q1 2023 May 11, 2023	BUY	$7.03 - $11.53 $24,654 - $40,435	3,507 Added 25.01%	17,530 $127,000
Q4 2022 Feb 13, 2023	BUY	$8.32 - $13.21 $116,671 - $185,243	14,023 New	14,023 $124,000
Q2 2022 Aug 12, 2022	SELL	$9.99 - $21.35 $1.98 Million - $4.23 Million	-198,110 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$39.27 - $72.94 $13,469 - $25,018	343 Added 0.17%	198,110 $8.14 Million
Q1 2021 May 14, 2021	SELL	$39.71 - $90.58 $962,689 - $2.2 Million	-24,243 Reduced 10.92%	197,767 $8.31 Million
Q4 2020 Feb 12, 2021	SELL	$27.07 - $84.35 $1.86 Million - $5.78 Million	-68,547 Reduced 23.59%	222,010 $15.6 Million
Q2 2020 Aug 13, 2020	SELL	$18.5 - $34.34 $949,642 - $1.76 Million	-51,332 Reduced 15.01%	290,557 $8.6 Million
Q1 2020 May 14, 2020	SELL	$14.88 - $32.78 $505,830 - $1.11 Million	-33,994 Reduced 9.04%	341,889 $6.78 Million
Q4 2019 Feb 12, 2020	BUY	$19.49 - $32.63 $9,511 - $15,923	488 Added 0.13%	375,883 $11.1 Million
Q3 2019 Nov 13, 2019	SELL	$22.49 - $26.81 $1.36 Million - $1.62 Million	-60,438 Reduced 13.87%	375,395 $8.54 Million
Q2 2019 Aug 14, 2019	BUY	$20.48 - $27.76 $1.02 Million - $1.38 Million	49,567 Added 12.83%	435,833 $10.8 Million
Q1 2019 May 14, 2019	BUY	$19.43 - $26.41 $769,272 - $1.05 Million	39,592 Added 11.42%	386,266 $0
Q4 2018 Feb 13, 2019	BUY	$18.19 - $31.79 $6.31 Million - $11 Million	346,674 New	346,674 $7.89 Million
Q2 2018 Aug 08, 2018	SELL	$31.4 - $41.01 $6.06 Million - $7.91 Million	-192,873 Closed	0 $0
Q1 2018 May 03, 2018	SELL	$29.84 - $44.08 $3.28 Million - $4.85 Million	-110,087 Reduced 36.34%	192,873 $6.39 Million
Q4 2017 Feb 02, 2018	SELL	$21.89 - $31.34 $202,898 - $290,490	-9,269 Reduced 2.97%	302,960 $9.31 Million
Q3 2017 Nov 01, 2017	BUY	$15.81 - $24.01 $4.94 Million - $7.5 Million	312,229	312,229 $7.5 Million

Others Institutions Holding EDIT

# of Institutions

247

Shares Held

57M

Call Options Held

410K

Put Options Held

394K

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $92.1M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Editas Medicine, Inc. Transaction History